These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28421623)

  • 21. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
    McCormick PN; Ginovart N; Wilson AA
    Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index.
    Caravaggio F; Raitsin S; Gerretsen P; Nakajima S; Wilson A; Graff-Guerrero A
    Biol Psychiatry; 2015 Jan; 77(2):196-202. PubMed ID: 23540907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reward motivation in humans and its relationship to dopamine D
    Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
    J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evaluation of the carbon11-labeled D(2/3) agonist PET radiotracer PHNO: reproducibility in tracer characteristics and characterization of extrastriatal binding.
    Egerton A; Hirani E; Ahmad R; Turton DR; Brickute D; Rosso L; Howes OD; Luthra SK; Grasby PM
    Synapse; 2010 Apr; 64(4):301-12. PubMed ID: 19957364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study.
    Caravaggio F; Borlido C; Wilson A; Graff-Guerrero A
    Clin Chim Acta; 2015 Sep; 449():60-2. PubMed ID: 25814099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [
    Girgis RR; Slifstein M; Brucato G; Kegeles LS; Colibazzi T; Lieberman JA; Abi-Dargham A
    Mol Psychiatry; 2021 Jun; 26(6):2504-2513. PubMed ID: 33154566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the relationship between social attachment and dopamine D
    Caravaggio F; Chung JK; Gerretsen P; Fervaha G; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
    Soc Neurosci; 2017 Apr; 12(2):163-173. PubMed ID: 26873034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Separating dopamine D
    Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
    Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary study of dopamine D2/3 receptor availability and social status in healthy and cocaine dependent humans imaged with [(11)C](+)PHNO.
    Matuskey D; Gaiser EC; Gallezot JD; Angarita GA; Pittman B; Nabulsi N; Ropchan J; MaCleod P; Cosgrove KP; Ding YS; Potenza MN; Carson RE; Malison RT
    Drug Alcohol Depend; 2015 Sep; 154():167-73. PubMed ID: 26164205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.
    Shotbolt P; Tziortzi AC; Searle GE; Colasanti A; van der Aart J; Abanades S; Plisson C; Miller SR; Huiban M; Beaver JD; Gunn RN; Laruelle M; Rabiner EA
    J Cereb Blood Flow Metab; 2012 Jan; 32(1):127-36. PubMed ID: 21878947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
    Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
    Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo binding of antipsychotics to D3 and D2 receptors: a PET study in baboons with [11C]-(+)-PHNO.
    Girgis RR; Xu X; Miyake N; Easwaramoorthy B; Gunn RN; Rabiner EA; Abi-Dargham A; Slifstein M
    Neuropsychopharmacology; 2011 Mar; 36(4):887-95. PubMed ID: 21178982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice.
    Rabiner EA; Slifstein M; Nobrega J; Plisson C; Huiban M; Raymond R; Diwan M; Wilson AA; McCormick P; Gentile G; Gunn RN; Laruelle MA
    Synapse; 2009 Sep; 63(9):782-93. PubMed ID: 19489048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
    Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
    Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.
    Suridjan I; Rusjan P; Addington J; Wilson AA; Houle S; Mizrahi R
    J Psychiatry Neurosci; 2013 Mar; 38(2):98-106. PubMed ID: 23010256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heightened Dopaminergic Response to Amphetamine at the D
    Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
    Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans.
    Caravaggio F; Borlido C; Hahn M; Feng Z; Fervaha G; Gerretsen P; Nakajima S; Plitman E; Chung JK; Iwata Y; Wilson A; Remington G; Graff-Guerrero A
    Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv014. PubMed ID: 25716779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
    Le Foll B; Payer D; Di Ciano P; Guranda M; Nakajima S; Tong J; Mansouri E; Wilson AA; Houle S; Meyer JH; Graff-Guerrero A; Boileau I
    Neuropsychopharmacology; 2016 Jan; 41(2):529-37. PubMed ID: 26089182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.